|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||20.62 - 24.43|
|52 Week Range||15.35 - 28.72|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.00|
SOUTH SAN FRANCISCO, Calif., September 08, 2021--Tenaya Therapeutics reported business and program updates and second quarter 2021 financial results.
SOUTH SAN FRANCISCO, Calif., August 31, 2021--Tenaya Therapeutics announced that it will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference.
SOUTH SAN FRANCISCO, Calif., August 03, 2021--Tenaya Therapeutics, Inc. announced today the closing of its underwritten, upsized initial public offering.